These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2458606)
1. Effects of phenylalkylamine calcium entry blockers on postischemic energy metabolism in the isolated perfused rat brain: stereoselective action of emopamil. Weber J; Bielenberg GW; Krieglstein J Pharmacology; 1988; 37(1):38-49. PubMed ID: 2458606 [TBL] [Abstract][Full Text] [Related]
2. Effects of calcium entry blocker emopamil on postischemic energy metabolism of the isolated perfused rat brain. Bielenberg GW; Haubruck H; Krieglstein J J Cereb Blood Flow Metab; 1987 Aug; 7(4):489-96. PubMed ID: 3611207 [TBL] [Abstract][Full Text] [Related]
3. Effects of cerebroprotective agents on cerebral blood flow and on postischemic energy metabolism in the rat brain. Bielenberg GW; Beck T; Sauer D; Burniol M; Krieglstein J J Cereb Blood Flow Metab; 1987 Aug; 7(4):480-8. PubMed ID: 3611206 [TBL] [Abstract][Full Text] [Related]
4. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile. Hofmann HP; Raschack M; Unger L Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655 [TBL] [Abstract][Full Text] [Related]
5. Effect of gallopamil on energy metabolism of the isolated perfused rat brain in the postischemic period. Weber J; Krieglstein J Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):451-4. PubMed ID: 4033809 [TBL] [Abstract][Full Text] [Related]
6. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 2nd communication: brain penetration, cerebral vascular and metabolic effects. Szabo L Arzneimittelforschung; 1989 Mar; 39(3):309-14. PubMed ID: 2757656 [TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of neuronal calcium entry and [3H]-D-aspartate release by the quaternary derivatives of verapamil and emopamil. Keith RA; Mangano TJ; DeFeo PA; Ernst GE; Warawa EJ Br J Pharmacol; 1994 Oct; 113(2):379-84. PubMed ID: 7834187 [TBL] [Abstract][Full Text] [Related]
8. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death. Szabo L; Hofmann HP Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657 [TBL] [Abstract][Full Text] [Related]
9. Calcium entry blockers protect brain energy metabolism against ischemic damage. Krieglstein J; Weber J Adv Exp Med Biol; 1986; 200():243-51. PubMed ID: 3799312 [No Abstract] [Full Text] [Related]
10. Effects of emopamil on postischemic blood flow and neuronal damage in rat brain. Bielenberg GW; Sauer D; Nuglisch J; Beck T; Rossberg C; Mennel HD; Krieglstein J Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):230-5. PubMed ID: 2725698 [TBL] [Abstract][Full Text] [Related]
11. Calcium antagonists in the treatment of experimental cerebral ischemia. Ginsberg MD; Lin B; Morikawa E; Dietrich WD; Busto R; Globus MY Arzneimittelforschung; 1991 Mar; 41(3A):334-7. PubMed ID: 1859503 [TBL] [Abstract][Full Text] [Related]
12. (R)-[¹¹C]Emopamil as a novel tracer for imaging enhanced P-glycoprotein function. Toyohara J; Okamoto M; Aramaki H; Zaitsu Y; Shimizu I; Ishiwata K Nucl Med Biol; 2016 Jan; 43(1):52-62. PubMed ID: 26429767 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel calcium channel blocker, (S)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury. Okiyama K; Smith DH; Thomas MJ; McIntosh TK J Neurosurg; 1992 Oct; 77(4):607-15. PubMed ID: 1527621 [TBL] [Abstract][Full Text] [Related]
14. Effect of dihydroergocristine on energy metabolism studied in the isolated perfused rat brain affected by ischemia and in neuroblastoma cells deprived of oxygen and glucose. Rachman A; Kellmann L; Krieglstein J J Cereb Blood Flow Metab; 1984 Dec; 4(4):610-4. PubMed ID: 6438125 [TBL] [Abstract][Full Text] [Related]
16. Calcium channel antagonists verapamil and gallopamil are powerful inhibitors of acid secretion in isolated and enriched guinea pig parietal cells. Sewing KF; Hannemann H Pharmacology; 1983; 27(1):9-14. PubMed ID: 6310646 [TBL] [Abstract][Full Text] [Related]
17. (S)-emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat. Nakayama H; Ginsberg MD; Dietrich WD Neurology; 1988 Nov; 38(11):1667-73. PubMed ID: 3185899 [TBL] [Abstract][Full Text] [Related]
18. (S)-emopamil protects against global ischemic brain injury in rats. Lin BW; Dietrich WD; Busto R; Ginsberg MD Stroke; 1990 Dec; 21(12):1734-9. PubMed ID: 2264081 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts. Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080 [TBL] [Abstract][Full Text] [Related]
20. Stereoisomers of calcium antagonists discriminate between coronary vascular and myocardial sites. van Amsterdam FT; Zaagsma J Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):213-9. PubMed ID: 3259292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]